Evidence map›Paper›PMID 33126450›Full record

ReviewPharmaceuticals (Basel, Switzerland)2020

Role of Kinins in Hypertension and Heart Failure.

Suhail Hamid, Imane A Rhaleb, Kamal M Kassem, Nour-Eddine Rhaleb

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Kinin BPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Factor XII Structure-Function Relationships.Seminars in thrombosis and hemostasis · 2024
    Review
  9. Kinin BInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  10. Article
  11. Review
  12. STING/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  13. Review
  14. Review
  15. Knockout of ACE-N facilitates improved cardiac function after myocardial infarction.Journal of molecular and cellular cardiology plus · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection.Journal of the renin-angiotensin-aldosterone system : JRAAS · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Suhail HamidHypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA.
Imane A RhalebHypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA.
Kamal M KassemDivision of Cardiology, Department of Internal Medicine, University of Louisville Medical Center, Louisville, KY 40202, USA.
Nour-Eddine RhalebHypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA.
Henry Ford Hospital · USUniversity of Louisville · USWayne State University · US

Funding

Ac-SDKP in the Treatment of Cardiac Dysfunction in Hypertension or Ischemic HeartR01HL136456 · NHLBI · WAYNE STATE UNIVERSITY · PI RHALEB, NOUR-EDDINE · 2018 to 2021
$1.9M
NHLBI NIH HHS R01 HL136456NIH HHS HL-136456
6 · The paper itself

Abstract

The kallikrein-kinin system (KKS) is proposed to act as a counter regulatory system against the vasopressor hormonal systems such as the renin-angiotensin system (RAS), aldosterone, and catecholamines. Evidence exists that supports the idea that the KKS is not only critical to blood pressure but may also oppose target organ damage. Kinins are generated from kininogens by tissue and plasma kallikreins. The putative role of kinins in the pathogenesis of hypertension is discussed based on human mutation cases on the KKS or rats with spontaneous mutation in the kininogen gene sequence and mouse models in which the gene expressing only one of the components of the KKS has been deleted or over-expressed. Some of the effects of kinins are mediated via activation of the B

Indexed as

angiotensin-converting enzymeangiotensin receptor blockersB1 and B2 receptorsbradykininhypertensionkallikrein–kinin systemmicemyocardial infarction

Identifiers

PMID33126450
PMCPMC7692223
OpenAlexW3096933616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.